(MENAFN- GlobeNewsWire - Nasdaq) AI in IVD market opportunities include increased demand for personalized medicine, rapid diagnostic solutions, early disease detection, and precision medicine. Growth driven by AI advancements in genomics, cloud solutions, and deep learning offers potential for innovation in diagnostic tools and healthcare digitization.Dublin, Dec. 02, 2025 (GLOBE NEWSWIRE) -- The "Artificial Intelligence (AI) in in Vitro Diagnostics (IVD) Market Report 2025" has been added to ResearchAndMarkets's offering.
![]()
The artificial intelligence (AI) in in vitro diagnostics (IVD) market is experiencing robust growth, projected to expand from $2.57 billion in 2024 to $3.04 billion in 2025, marking a compound annual growth rate (CAGR) of 18.5%. This upward trend continues, with market size anticipated to reach $5.94 billion by 2029 at a CAGR of 18.2%. Key drivers include the need for rapid diagnostic results, prevalence of chronic diseases, and the demand for personalized medicine.
Advancements in AI-driven diagnostics are transforming healthcare, particularly in the realm of personalized medicine. By evaluating complex patient data, AI supports tailored treatment plans, enhancing diagnostic accuracy. The FDA's 2024 approval of 16 personalized treatments highlights this trend, notably in rare diseases and cancer, reflecting the growing reliance on personalized medicine in the medical field.
Companies like Diagnostics are pushing the envelope with innovations like a cutting-edge solution launched in May 2025. This platform automates PCR result interpretation with over 99.9% accuracy, streamlining workflows and ensuring high diagnostic precision. PCR sets a benchmark in regulatory compliance and clinical trust, significantly improving laboratory efficiency and reducing error margins.
Strategic collaborations are also advancing the sector. In April 2025, bioMerieux SA partnered with Mila, a leading AI research institute, to enhance diagnostic tools, with a focus on antibiotic resistance detection. Such partnerships underscore the importance of integrating AI with diagnostic technology to tackle critical medical challenges.
Market leaders include Roche Diagnostics GmbH, Thermo Fisher Scientific Inc., and Abbott Laboratories, among others. These key players are strengthening their positions with AI-enabled technologies that refine diagnostic processes. Regional market dynamics reveal North America as the largest and Asia-Pacific as the fastest-growing market, reflecting diverse consumer demands and technological adoption rates.
The market's evolution is not without challenges. Trade tensions and tariffs, particularly those arising in 2025, pose risks to supply chains and cost structures. Companies are adopting strategies like dual-sourcing and increased domestic production to mitigate these issues, highlighting the sector's resilience and adaptability in a shifting global landscape.
AI in IVD encompasses software, hardware, and service components leveraging cutting-edge technologies like machine learning and natural language processing. Applications range from diagnostic imaging to genomics, serving end users across hospitals, clinics, and pharmaceutical firms.
Delivering comprehensive insights, the AI in IVD market report provides critical statistics, competitor analysis, and strategic guidance, invaluable for stakeholders navigating the complex healthcare ecosystem. With an emphasis on real-time data and future trends, the report is an essential tool for understanding market dynamics and capitalizing on emerging opportunities.
Key Benefits of the Report:
Gain unparalleled global insights with coverage across 15 key geographies. Assess macroeconomic impacts such as geopolitical conflicts, trade policies, post-pandemic supply chain issues, inflation, and interest rates. Formulate region-specific strategies grounded in localized data and analysis. Identify lucrative growth segments for targeted investment. Leverage forecasting data to gain a competitive edge. Understand market dynamics through updated market share insights. Benchmark your performance against leading market players. Enhance presentations using high-quality data and in-depth analysis. Receive timely updates and Excel data sheets for seamless data extraction and analysis.
Key Attributes:
Artificial Intelligence (AI) in in Vitro Diagnostics (IVD) Market Characteristics
Artificial Intelligence (AI) in in Vitro Diagnostics (IVD) Market Trends and Strategies
Artificial Intelligence (AI) in in Vitro Diagnostics (IVD) Market Macro Economic Scenario
Global Artificial Intelligence (AI) in in Vitro Diagnostics (IVD) Growth Analysis and Strategic Analysis Framework
Artificial Intelligence (AI) in in Vitro Diagnostics (IVD) Market Regional and Country Analysis
CONTACT:
CONTACT:
Laura Wood,Senior Press Manager...
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Comments
No comment